4701 Sangamore Road, #100N
Bethesda, MD 20816
We have reinvented Naloxone.

Pocket Naloxone Corp.

Launching a clinically superior, cost effective and widely accessible Naloxone product.

70,000 +

Opioid Overdose Deaths

Every 8 minutes, someone in America dies from an opioid overdose. There were over 70,000 opioid overdose deaths in 2020

35,000,000 +

At Risk of An Overdose

This population comprises about 19M high-impact chronic pain patients taking higher doses of opioids, about 11M misusing heroin or fentanyl primarily to alleviate pain, and others on opioid use disorder treatments

140,000,000 +

Opioid Prescriptions Written

142,816,781 opioid prescriptions were written in 2020. This corresponds to a dispensing rate of 43.3 prescriptions per 100 persons


See Us at ASAM 2022.

We are looking forward to presenting our exciting clinical data at the American Society of Addiction Medicine's Spring Conference March 31-April 3, 2022.

Recent Developments

NIDA Grant Announcement.

Apart from our exciting clinical study results, we are also pleased to be awarded a NIDA grant in September, 2021 to bring our life saving Naloxone product to market ASAP. This grant is part of the NIH Heal Initiative. The Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, supports a wide range of programs to develop new or improved prevention and treatment strategies for opioid addiction. Pocket Naloxone Corp. looks forward to this public-private partnership and to bring our game-changing Naloxone product to market ASAP. Pocket Naloxone is easy-to-use, will be widely accessible, and significantly improves on the clinical performance of available products.